Determination of bone and tissue concentrations of teicoplanin mixed with hydroxyapatite cement to repair cortical defects

Journal of Biochemical and Biophysical Methods

Volumn 53, Issue 1-3, 2002, Pages 51-59

  Eggenreich, K ^a   Zeipper, U ^a   Schwendenwein, E ^b   Hadju, S ^b   Kaltenecker, G ^b   Laslo, I ^c   Lang, S ^b   Roschger, P ^d,e   Vecsei, V ^b   Wintersteiger, R ^a,f  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c University of Trgu Mure Medical School Trgu Mure   (Romania)

^d HANUSCH HOSPITAL   (Austria)

^e Trauma Center Meidling   (Austria)

^f Fax: +43 316 380 9846 ^*  (Austria)

Author keywords

Determination in tissue; Fluorescence derivatization; OPA; Stability in bone cement; Teicoplanin

Indexed keywords

BONE CEMENT; HYDROXYAPATITE; TEICOPLANIN; FLUORESCAMINE; HYDROXYAPATITE CEMENT; PHTHALALDEHYDE;

ANIMAL TISSUE; BONE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; CORTICAL BONE; DERIVATIZATION; DRUG BONE LEVEL; DRUG DEGRADATION; FLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TISSUE LEVEL; ANIMAL; ARTICLE; BACTERIAL INFECTION; BONE; CEMENTATION; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; FRACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATERIALS TESTING; METABOLISM; METHODOLOGY; RABBIT; SPECTROFLUOROMETRY;

ANIMALS; BONE AND BONES; BONE CEMENTS; CEMENTATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCAMINE; FRACTURES, BONE; GRAM-POSITIVE BACTERIAL INFECTIONS; HYDROXYAPATITES; MATERIALS TESTING; O-PHTHALALDEHYDE; RABBITS; SPECTROMETRY, FLUORESCENCE; TEICOPLANIN;

EID: 0036804722     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(02)00092-1     Document Type: Conference Paper

References (12)

1. Kveton J.F. Obliteration of the eustachian tube using hydroxyapatite cement: a permanent technique. Laryngoscope. 106:1996;1241-1243.
2. Weissman J.L., Snyderman C.H., Hirsch B.E. Hydroxyapatite cement to repair skull base defects. Am. J. Neuroradiol. 17:1996;1569-1574.
3. Mastin S.H., Buck R.L., Mueggler P.A. Performance of a fluorescence polarization immunoassay for teicoplanin in serum. Diagn. Microbiol. Infect. Dis. 16(1):1993;17-24.
4. Zeckel M.L. A closer look at vancomycin; teicoplanin and antimicrobial resistance. J. Chemother. 9(5):1997;311-335.
5. William A.H., Gruneberg R.N. Teicoplanin revisited. J. Antimicrob. Chemother. 22:1988;397.
6. Taylor R.B., Reid R.G. Determination of teicoplanin in plasma using microbore high performance liquid chromatography and injection generated gradients. J. Chromatogr. 563:1991;451-457.
7. Riva E. Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high performance liquid chromatography. J. Chromatogr. 421:1987;99-110.
8. Jehl F., Gallion C., Monteil H. High performance liquid chromatography of antibiotics. J. Chromatogr. 531:1990;509-548.
9. Chapelle G., Bouquet S., Rivet G., Barrier L., Rochard E., Courtios P.H. Rapid determination of teicoplanin in human plasma by high performance liquid chromatography. J. Liq. Chromatogr. 14(11):1991;2157-2167.
10. Joos B., Lüthy R. Identification of fluorescent glycopeptide derivatives by two consecutive high performance liquid chromatographic procedures. J. Antibiot. 41(3):1988;302-307.
11. Schwendenwein E, Hajdu ST, Kaltenecker G, László I, Lang S, Roschger P, et al., Hydroxyapatite cement (bone source) for the repair of cortical defects - An experimental study on rabbits. J. Orthop. Res. (in press).
12. Joos B., Lüthy R. Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography. Antimicrob. Agents Chemother. 31:1987;1222-1224.